Preview

"Arterial’naya Gipertenziya" ("Arterial Hypertension")

Advanced search

Mechanisms for compensation of pulmonary hypertension in chronic obstructive pulmonary disease

https://doi.org/10.18705/1607-419X-2018-24-3-339-350

Abstract

Despite multiple risk factors of pulmonary hypertension (PH) are known, the true incidence of PH remains undefined in patients with severe bronchial obstruction. Objective. The aim of the study was to identify mechanisms of compensation of the increase in pulmonary artery pressure and to determine their prognostic role. Design and methods. The results of a complex clinical and radiological studies of 200 patients with COPD II (B), and 207 patients with COPD III (D), and COPD IV (D), (GOLD 2017) were analyzed. A comparative analysis of changesin pulmonary circulation in patients (n = 8) with primary PH was performed. Male subjects predominated among the examined patients with COPD (90,6  %), the average age of patients with COPD II was 54,0 ± 6,3 years, in patients with COPD III–IV stages — 63,9 ± 5,8 years. The average age of patients with primary PH was 38,7 ± 7,9 years. The following diagnostic methods were performed: single-photon emission computer tomography, multidetector computed tomography, external respiration function, echocardiography. Results. In patients with COPD II (B), both ventilation and perfusion disorders developed, the diffusion capacity of the lungs decreased and the intrapulmonary shunting of the blood occurred. Despite overall decrease in pulmonary perfusion, local zones of increased blood flow appeared in the unchanged pulmonary parenchyma. This compensation mechanism was observed in 54,6  % of patients and was accompanied by partial decrease of pressure in the pulmonary artery to values close to normal. In severe COPD, 44,4  % patients developed hyperperfusion zones, but without any compensatory effect. In such cases, pressure reduction in the pulmonary artery system was promoted by the development of blood bypass, which was observed only in 10  % cases. Conclusions. We can speculate that the mechanism of compensation of increased pressure in the pulmonary artery and reduction of PaO2 results from the development of local zones of increased blood flow in the unchanged pulmonary parenchyma, but in severe bronchial obstructive pathology it causes the formation of blood shunting.

About the Authors

V. P. Zolotnitskaya
First Pavlov State Medical University of St. Petersburg
Russian Federation

Doctor of Biological Sciences, Senior Researcher, Department of Chronic Obstructive Pathology of the Lung, Research Institute of Pulmonology,

6–8 Lev Tolstoy street, St Petersburg, 197022



T. D. Vlasov
First Pavlov State Medical University of St. Petersburg
Russian Federation

MD, PhD, DSc. Professor, Head, Department of Pathological Physiology with the Course of Clinical Pathophysiology,

6–8 Lev Tolstoy street, St Petersburg, 197022



V. I. Amosov
First Pavlov State Medical University of St. Petersburg
Russian Federation

MD, PhD, DSc, Professor, Head, Department of Roentgenology and Radiation Medicine,

6–8 Lev Tolstoy street, St Petersburg, 197022



O. V. Lukina
First Pavlov State Medical University of St. Petersburg
Russian Federation

MD, PhD, DSc, Associate Professor, Department of Roentgenology and Radiation Medicine,

6–8 Lev Tolstoy street, St Petersburg, 197022



A. O. Agafonov
First Pavlov State Medical University of St. Petersburg
Russian Federation

MD, Postgraduate Student, Department of Roentgenology and Radiation Medicine,

6–8 Lev Tolstoy street, St Petersburg, 197022



References

1. Кароли Н.А., Ребров А.П. Эндотелиальная дисфункция и ее клиническое значение у больных хронической обструктивной болезнью легких. Клиническая медицина. 2005;9:10–16. [Karoli NA, Rebrov AP. Endothelial dysfunction and its clinical significance in patients with chronic obstructive pulmonary disease. Clinical Medicine. 2005;9:10–16. In Russian].

2. Кузубова Н.А., Гичкин А.Ю., Перлей В.Е. Вазорегулирующая функция эндотелия у больных хронической обструктивной болезнью легких и возможности ее медикаментозной коррекции. Вестник современной клинической медицины. 2010;3(3):21–26. [Kuzubova NA, Gichkin AYu, Perley VE. Vasoregulating function of the endothelium in patients with chronic obstructive pulmonary disease and the possibility of its medication correction. Bulletin of Modern Clinical Medicine. 2010;3(3):21–26. In Russian].

3. Киняйкин М.Ф., Суханова Г.И., Рассохина Н.Ю., Крамар А.В. Влияние гипоксемии на некоторые клинико-функциональные показатели, характеризующие качество жизни больных хронической обструктивной болезнью легких. Тихоокеанский медицинский журнал. 2012;1(47):77–79. [Kinyaikin MF, Sukhanova GI, Rassokhina NYu, Kramar AV. Influence of hypoxemia on some clinico-functional indicators characterizing the quality of life of patients with chronic obstructive pulmonary disease. Pacific Medical Journal. 2012;1(47):77–79. In Russian].

4. Макарова М.А., Авдеев С.Н. Артериальная ригидность и эндотелиальная дисфункция у больных хронической обструктивной болезнью легких. Пульмонология. 2011;4:109–117. [Makarova MA, Avdeev SN. Arterial stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease. Pulmonology. 2011;4:109–117. In Russian].

5. Булдакова И.А., Григоренко А.А. Изменения артериального сосудистого русла при хронической обструктивной болезни легких. Дальневосточный медицинский журнал. 2011;4:115–118. [Buldakova IA, Grigorenko AA. Changes in the arterial vascular bed in chronic obstructive pulmonary disease. Far Eastern Medical Journal. 2011;4:115–118. In Russian].

6. Жук О.А., Перлей В.Е., Гичкин А.Ю., Александров А.Л., Титова О.Н., Кузубова Н.А. Оценка ранних признаков дисфункции правых камер сердца у пациентов с ХОБЛ. Уральский медицинский журнал. 2017;7:112–115. [Zhuk OA, Perley VE, Gichkin AYu, Aleksandrov AL, Titova ON, Kuzubova NA. Assessment of early signs of right heart chamber dysfunction in patients with COPD. 2014;7:112–115. In Russian].

7. Царева Н.А., Авдеев С.Н., Науменко Ж.К., Неклюдова Г.В. Легочная гипертензия.M.: ГЭОТАР-Медиа, 2015. 416. [Tsareva NA, Avdeev SN, Naumenko ZhK, Neklyudova GV. Pulmonary hypertension. Moscow: GEOTAR-Media, 2015. 416. In Russian].

8. Авдеев С.Н. Можно ли улучшить прогноз у больных хронической обструктивной болезнью легких? Пульмонология. 2015;4:469–476. [Avdeev SN. Is it possible to improve the prognosis in patients with chronic obstructive pulmonary disease? Pulmonology. 2015;4:469–476. In Russian].

9. Мартынюк Т.В., Чазова И.Е., Наконечников С.Н. Легочная гипертензия: актуальные вопросы диагностики и лечения. Фарматека. 2012;5(238):52–56. [Martynyuk TV, Chazova IE, Nakonechnikov SN. Pulmonary hypertension: topical issues of diagnosis and treatment. Pharmateka. 2012;5(238):52–56. In Russian].

10. Черногорюк Г.Э., Рослякова Е.П., Михайлова А.А. Рачковский М. И., Варвянская Н. В., Санжаровская М. С., Антипов С. И. и др. Фенотип малых макрофагов в индуцированной мокроте — маркер ранней стадии хронической обструктивной болезни. Современные проблемы науки и образования [Электронный научный журнал]. 2014;6:11–34. Доступ: http://www.science-education.ru/120–16430/. [Chernoruryuk GE, RoslyakovaEP, MikhailovaAA, RachkovskiyMI, VarvyanskayaNV, Sanzharovskaya MS, Antipov SI, et al. The phenotype of small macrophages in induced sputum is a marker of the early stage of chronic obstructive disease. Modern problems of science and education [Electronic resource]. 2014;6:11–34. Available from: http://www.science-education.ru/120–16430/ In Russian].

11. Chong J, Poole P, Leung B, Black PN. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;5: CD002309. doi:10.1002/14651858.CD002309.pub3

12. Агеева Т.С., Дубоделова А.В., Кривоногов Н.Г. Дополнительные возможности оптимизации дифференциальной диагностики бронхиальной астмы и ХОБЛ. Дневник казанской медицинской школы. 2013;2:78–81. [Ageeva TS, DubodelovaAV, Krivonogov NG. Additional possibilities for optimization of differential diagnostics of bronchial asthma and COPD. Diary of Kazan Medical School. 2013;2:78–81. In Russian].

13. Гриппи М.А. Патофизиология легких. 2 е изд., испр. М.: Бином, 2014. 304 с. [Grippie МА. Pathophysiology of the lungs. 2nd edition. Moscow: Binom, 2014. 304 p. In Russian].

14. Шанин В.Ю. Клиническая патофизиология. Учебник для медицинских вузов. CПб.: Специальная литература, 1998. 569 с. [Shanin VYu. Clinical pathophysiology. Textbook for medical high schools. St Petersburg: Special Literature. 1998. 569 p. In Russian].

15. Шпагина Л. А., Воевода М. И., Котова О.С., Максимов В.Н., Орлов П.С., Шпагин И.С. и др. Профессиональная хроническая обструктивная болезнь легких с позиций молекулярно-генетических исследований. Бюллетень физиологии и патологии дыхания. 2013; 2(49):8–15. [Shpagina LA, Voevoda MI, Kotova OS, Maksimov VN, Orlov PS, Shpagin IS, et al. Professionally-associated chronic obstructive pulmonary disease from the standpoint of molecular genetic studies. Bulletin of the physiology and pathology of respiration. 2013; 2(49):8–15. In Russian].

16. Boschetto P, Beghe B, Fabrbri LM, Ceconi C. Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice. Respirology. 2012;17 (3):422–431.

17. Cottin V, Le Pavec, Prevot G. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J. 2010; 35(1):105–111.

18. Емельянов А.В. Cовременная терапия хронической обструктивной болезни легких. Лечащий врач. 2004;8:31–38. [Emel’yanov AV. Actual therapy of chronic obstructive pulmonary disease. The Attending Physician. 2004;8:31–38. In Russian].

19. Авдеев С. Н. Нарушения газообмена при хронической обструктивной болезни легких. Русский медицинский журнал. 2013;7:353. [Avdeev SN. Disorders of gas exchange in chronic obstructive pulmonary disease. Russian Medical Journal. 2013;7:353. In Russian].

20. Чазова И.Е., Мартынюк Т.В. Легочная гипертензия.М.: Практика, 2015. 928 c. [Chazova IE, Martynyuk TV. Pulmonary hypertension. Moscow: Practika, 2015. 928 p. In Russian].

21. Уклистая Т. А., Полунина О. С., Галимзянов Х. М., Мартиросян Е.Ф. Полиморфизм генов провоспалительных цитокинов при хронической обструктивной болезни легких, ассоциированной с сердечно-сосудистой патологией. Кубанский медицинский вестник. 2011;6(129):169–173. [Uklistaya TA, Polunina OS, Galimzyanov KhM, Martirosyan EF. Polymorphism of the genes of proinflammatory cytokines in chronic obstructive pulmonary disease associated with cardiovascular pathology. 2011;6 (129):169–173. In Russian].

22. Bowler RP, Barnes PJ, Crapo JD. The role of oxidative stress in chronic obstructive pulmonary disease. COPD. 2004;1 (2):255–277.

23. Orr R, Smith LJ, Cuttica MJ. Pulmonary hypertension in advanced chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2012;18(2):138–143.

24. Stone AC, Machan JT, Mazer J, Casserly B, Klinger JR. Echocardiographic evidence of pulmonary hypertension is associated with increased 1 year mortality in patients admitted with chronic obstructive pulmonary disease. Lung. 2011;189 (3):207–212.

25. Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T. Lung volumes and emphysema in smokers with interstitial lung abnormalities. New England Journal of Medicine. 2011;364(10):897–906.

26. Быканова А.В. Морфофункциональная характеристика легочных и бронхиальных артерий при бронхиальной астме, хронической обструктивной болезни легких, идиопатическом фиброзирующем альвеолите: автореф. дис. … канд. мед. наук. М., 2007. [Bykanova AV. Morphofunctional characteristics of pulmonary and bronchial arteries in bronchial asthma, chronic obstructive pulmonary disease, idiopathic fibrosing alveolitis. PhD thesis. Moscow, 2007. In Russian].

27. Черняев А.Л., Самсонова М.В. Варианты хронической обструктивной болезни легких с позиции патологоанатома. Пульмонология. 2013;3:93–96. [Chernyaev AL, Samsonova MV. Variants of chronic obstructive pulmonary disease from the position of a pathologist. Pulmonology. 2013;3:93–96. In Russian].

28. Каро К., Педли Т., Шротер Р., Сид У. Механика кровообращения.М.: Мир, 1981. 624 с. [Caro K, Pedley T, Shroter R, Sid U. Mechanics of blood circulation. Moscow: Mir, 1981. 624 p. In Russian].

29. Daly JD. Veno-arterial shunting in obstructive pulmonary disease. N Engl J Med. 1968;278(1):952–953.

30. Авдеев С.Н. Дыхательная недостаточность. Атмосфера, Пульмонология и аллергология. 2004;1:21–26. [Avdeev SN. Respiratory failure. Atmosphere, pulmonology and allergology. 2004;1:21–26. In Russian].

31. Белебезьев Г. И, Козяр В.В. Физиология и патофизиология искусственной вентиляции легких.К.: Ника-Центр, 2003. 312 с. [Belebezev GI, Kozyar VV. Physiology and pathophysiology of mechanical ventilation of lungs.K.: Nika-Tsentr, 2003. 312 р. In Russian].

32. Левитэ Е. М., Уклонский А. Н. Роль шунтирования в легких в развитии дыхательной недостаточности. Вестник КРСУ. 2014;14(5):75–78. [Levitе EM, Uglonsky AN. The role of bypassin the lungsin the development of respiratory failure. Vestnik KRSU. 2014;14(5):75–78. In Russian].

33. Kudnig ST, Monnet E, Riquelme M, Gaynor JS, Corliss D, Salman MD. Effect of one lung ventilation on oxygen delivery in anesthetized dogs with an open thoracic cavity. Am J Vet Res. 2003;64(4):443–451.

34. Pfitzner J, Pfitzner L. The theoretical basis for using apnoeic oxygenation via the non-ventilated lung during onelung ventilation to delay the onset of arterial hypoxaemia. Anaesth. Intensive Care. 2005;33(6):794–800.

35. Адо А.Д., Тетенев Ф.Ф. Патофизиология внешнего дыхания (глава 15.1): под ред. проф. В.В. Новицкого и Е.Д. Гольдберга. В: Патофизиология: учебник для студентов высших медицинских учебных заведений. 2 е изд., доп. и перераб.. Томск: изд-во Томского университета, 2001. С. 503–525. Ado AD, Tetenev FF. Pathophysiology of external respiration (Chapter 15.1). Ed. Prof. Novitsky VV and Goldberg ED. In: Pathophysiology: Textbook for students of high medical schools. Edition 2, augmented and revised. Tomsk: publishing house of Tomsk University, 2001. P. 503–525. In Russian].

36. Castro PF, Bourge RC, McGiffin DC, Benza RL, Fan P, Pinkard NB. Intrapulmonary shunting in primary pulmonary hypertension: an observation in two patients treated with epoprostenol sodium. Chest. 1998;114(1):334–340.

37. Gartner R, Griffe O, Captier G, Selloumi D, Otman S, Brabet M et al. Аcute respiratory insufficiency in burn pаtients from smoke inhalation. Pathol Biol. 2002;50(2):118–120.

38. Eldridge MW, Dempsey JA, Haverkamp HC, Lovering AT, Hokanson JS. Exercise-induced intrapulmonary arteriovenous shunting in healthy humans. J Appl Physiol. 2004;97(3):797–805.

39. Пачерских Ф. Н. Легочная артериальная гипертензия: клиника, диагностика, лечение. Иркутск: изд-во ИГМУ, 2015. 94 c. [Patschersky FN. Pulmonary arterial hypertension: clinical picture, diagnosis, treatment. Irkutsk: ISMU, 2015. 94 p. In Russian].

40. Черняев А.Л., Самсонова М.В. Воспаление при хронической обструктивной болезни легких: молекулярные основы патогенеза. Consilium Medicum Ukraina. 2011;1:9–16. [Chernyaev AL, Samsonova MV. Inflammation in chronic obstructive pulmonary disease: the molecular basis of the pathogenesis. Consilium Medicum Ukraina. 2011;1:9–16. In Russian].

41. Лукина О. В. Лучевая диагностика тромбоэмболии легких у больных с эмфизематозным фенотипом хронической обструктивной болезни легких. Регионарное кровообращение и микроциркуляция. 2013;12(1):34-38. [Lukina OV. Radiological diagnosis of pulmonary thromboembolism in patients with emphysematous phenotype of chronic obstructive pulmonary disease. Regional Blood Circulation and Microcirculation. 2013;12 (1):34–38. In Russian].


Review

For citations:


Zolotnitskaya V.P., Vlasov T.D., Amosov V.I., Lukina O.V., Agafonov A.O. Mechanisms for compensation of pulmonary hypertension in chronic obstructive pulmonary disease. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2018;24(3):339-350. (In Russ.) https://doi.org/10.18705/1607-419X-2018-24-3-339-350

Views: 2705


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)